RBM30 recruits DOT1L to activate STAT1 transcription and drive immune evasion in hepatocellular carcinoma. Han H, Gong C, Zhang Y, Liu C, et al. Oncogene 2025 Aug 29. doi: 10.1038/s41388-025-03550.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Han H, Gong C, Zhang Y, Liu C, et al. RBM30 recruits DOT1L to activate STAT1 transcription and drive immune evasion in hepatocellular carcinoma. Oncogene 2025 Aug 29. doi: 10.1038/s41388-025-03550.
PMID: 40883414